Share on

Middle East & Africa Infection Control Market Analysis Report – Segmented By Products and Services, End-User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 11764
Pages: 100
Formats: report pdf report excel report power bi report ppt

MEA Infection Control Market Size (2022 to 2027)

The Middle East and Africa infection control market size is forecasted to be growing at a healthy CAGR during the forecast period.

The increasing prevalence of nosocomial infections/Hospital Acquired Infections (HAIs), increasing geriatric population, increasing demand for surgical procedures, and strategic government initiatives are significant drivers expected to drive the MEA infection control during the forecast period.

According to the CDC, up to 1.9 million hospital patients contract health care-associated infections (HAIs) each year while receiving treatment for other health conditions, and more than 99,000 these patients (one in 18) die from HAI. In addition, 36% of all HAIs are urinary tract infections, 25% are surgical site infections, 16% are lung infections (pneumonia), and 18% are blood infections. This should stimulate the demand for sterilization and disinfectant products. The incidence of HAIs depends primarily on the patient's immunological status, infection control practices, and the prevalence of various infectious agents in the health facility.

The factors further accelerating the infection control market in the Middle East and Africa can be largely attributed to the increasing incidence of chronic diseases; the growing importance given to the sterilization and disinfection of food; technological advances in sterilization equipment; and the increasing outsourcing of sterilization services between pharmaceutical companies, hospitals, and medical device manufacturers.

However, a lack of an unskilled workforce and apprehensions about the safety of reprocessed instruments are expected to hamper the growth of the infection control market. On the other hand, concerns about the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, together with factors such as the high cost of reprocessing endoscopes, limited reimbursement in developing countries, and end-user non-compliance with sterilization standards, may hamper the market's growth.

Healthcare workers play an important role in promoting seasonal influenza vaccination for their patients. Most healthcare workers accept that they are in good health. That way, they will not benefit from the vaccination or that the danger of hostile opportunities after vaccination outweighs the benefits. Vaccination of healthcare workers could potentially benefit healthcare professionals, their patients, and their families by reducing the transmission of microorganisms in healthcare.

Impact of COVID-19 on the MEA infection control market:

Currently, with the increase in COVID-19 cases, there is an increasing emphasis on personal hygiene and the increased production of medical nonwovens and single-use products such as masks and gloves. This, in turn, is expected to drive market growth over the next two years. . Factors such as the growing demand for hospital and intensive care beds in North America, the proliferation of isolation facilities, and growing consumer awareness of hygiene and preventive health care have greatly boosted demand for surface disinfectants.

However, in the worst-case scenario, supply disruptions due to prolonged shutdowns in several countries can significantly impact the manufacturing of medical and pharmaceutical devices and, in turn, significantly affect the demand for products from infection control by these end-users.

This research report on the Middle East and Africa infection control market has been segmented and sub-segmented into the following categories.

By-Products and Services:

  • Cleaning and disinfection products
  • Sterilization products and services
  • Endoscope reprocessing products
  • Protective equipment
  • Others

By End-User:

  • Hospitals and clinics
  • Medical device companies
  • Pharmaceutical companies
  • Life sciences companies
  • Food Industry
  • Others

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, South Africa is expected to grow during the forecast period. The country is also booming due to the growing number of companies, R&D capabilities, and the growing demand for infection control products.

The large share of the region can be attributed to the increasing demand and adoption of sterilization and disinfection products and services due to the growing emphasis on healthy lifestyles and disease prevention among people. In addition, the increase in the geriatric population in the coming years and the consequent increase in the prevalence of chronic diseases, the need for infection control to minimize the prevalence of HAIs, and the implementation of supportive government initiatives and Strict sterilization and disinfection regulations are also driving the infection control market in the region.


3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group are some of the notable players in the MEA infection control market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample